Skip to the answer

Trofinetide Uses, Dosage, Side Effects and Interactions

Brand names
Daybue

Daybue was approved by the FDA in March 2023 as an oral solution. No generic is listed as oral solution.

First generic of Daybue: our estimate, 2038 to 2039

Daybue Stix

Daybue Stix was approved by the FDA in December 2025 as an oral solution. No generic is listed as oral solution.

First generic of Daybue Stix: our estimate, 2038 to 2039

Trofinetide is a prescription medicine used to treat Rett syndrome in adults and children 2 years of age and older.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About TrofinetideType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Trofinetide in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Trofinetide (Daybue) is the first medicine approved specifically for Rett syndrome in adults and children 2 and older. It is a specialist drug, on the market only since about 2022, with no generic yet, and how it works is still unknown. Diarrhea is the side effect most people notice, usually mild to moderate but often lasting, and vomiting, poor appetite and weight loss can follow. Watch hydration and weight closely, and call the care team early if diarrhea turns severe or dehydration seems likely. Rett syndrome already raises the risk of aspiration (stomach contents getting into the lungs), so coughing or trouble breathing after vomiting needs urgent care.

Key Takeaways From the HelloPharmacist Team

  • Give it twice a day, morning and evening, by mouth or through a G-tube, with or without food.
  • Stop any laxatives before the first dose, and plan for extra fluids from day one since diarrhea is expected.
  • If a dose is missed or vomited up, skip it and give the next one at the usual time, never doubling up.
  • Check with your pharmacist before using loperamide or starting other medicines, since trofinetide can raise blood levels of loperamide and many other drugs.

How we write and review this content: our editorial policy

Trofinetide by the Numbers

Strengths
4
in one form
Makers and packagers
1
Earliest FDA record
2022
Rank by Medicaid prescriptions
#1,086 of 1,682 drugs
More prescriptions than 35% of the 1,682 drugs we measure
4,625 prescriptions, Q1–Q4 2025

Patient Information Guide for Trofinetide

What It’s Used For

Trofinetide is used for one condition.

  • Rett syndrome in adults and pediatric patients 2 years of age and older (Daybue and Daybue Stix).

How It Works

The way trofinetide helps people with Rett syndrome is not known. Researchers have not pinned down its exact mechanism.

Drug Class

How It Works

  • Cytochrome P450 3A4 Inhibitors
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)

None listed for Trofinetide in the FDA’s index.

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Cytochrome P450 3A4 Inhibitors
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors
  • Organic Anion Transporting Polypeptide 1B3 Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Trofinetide in the FDA’s index.

From our Patient Information GuideThe way trofinetide helps people with Rett syndrome is not known. Researchers have not pinned down its exact mechanism. Read How Trofinetide Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Trofinetide in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other nervous system drugs

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Trofinetide is taken by mouth or through a G tube twice daily, morning and evening, with or without food. The amount is based on body weight and kidney function.

  • Daybue oral solution: measure with an oral syringe or dosing cup from the pharmacy.
  • Daybue Stix: dissolve the whole packet in water or a water-based drink and give right away.
  • Missed dose: take the next dose as scheduled and do not double up.
  • Vomiting after a dose: do not repeat it. Take the next scheduled dose.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Rett syndrome

Patients 2 years and older weighing 9 kg to less than 12 kg Usual dose 5,000 mg twice a day

Good to know

Twice daily, morning and evening, with or without food

Patients 2 years and older weighing 12 kg to less than 20 kg Usual dose 6,000 mg twice a day

Good to know

Twice daily, morning and evening, with or without food

Patients 2 years and older weighing 20 kg to less than 35 kg Usual dose 8,000 mg twice a day

Good to know

Twice daily, morning and evening, with or without food

Patients 2 years and older weighing 35 kg to less than 50 kg Usual dose 10,000 mg twice a day

Good to know

Twice daily, morning and evening, with or without food

Patients 2 years and older weighing 50 kg or more Usual dose 12,000 mg twice a day

Good to know

Twice daily, morning and evening, with or without food

9 kg to under 12 kg Dose 2,500 mg twice daily

Good to know

Use Daybue oral solution to administer this dosage

12 kg to under 20 kg Dose 3,000 mg twice daily
20 kg to under 35 kg Dose 4,000 mg twice daily
35 kg to under 50 kg Dose 5,000 mg twice daily
Patients with moderate kidney problems weighing 50 kg or more Dose 6,000 mg twice daily

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects are diarrhea and vomiting. Others reported more often than with placebo include:

Common side effects

  • Diarrhea
  • Vomiting
  • Fever
  • Seizure
  • Anxiety
  • Decreased appetite
  • Fatigue
  • Nasopharyngitis (stuffy or runny nose, common cold symptoms)

When to get medical help

  • Tell your healthcare provider if diarrhea starts, especially if it is severe or you suspect dehydration.
  • Call your provider if there is significant weight loss.
  • Get help if vomiting is severe or keeps happening despite treatment.
  • Seek urgent care for signs of aspiration (stomach contents or fluid getting into the lungs) or aspiration pneumonia after vomiting.

Contact your provider for severe diarrhea, signs of dehydration, notable weight loss, or severe or persistent vomiting.

Warnings and Precautions

  • Diarrhea: very common and sometimes persistent. Stop laxatives before starting, drink more fluids, and tell your provider.
  • Weight loss: weight should be monitored. Treatment may be paused, reduced, or stopped if it is significant.
  • Vomiting: aspiration and aspiration pneumonia have occurred afterward, and people with Rett syndrome are at higher risk.

Interactions

Trofinetide can raise levels of certain other medicines.

  • CYP3A and P-gp substrates: trofinetide inhibits these pathways, which may increase the effects of drugs that depend on them, so close monitoring is advised.
  • Loperamide: blood levels rose in a study when taken with trofinetide.
  • Laxatives: stop before starting, since diarrhea is common.

Interactions Listed in the FDA-Approved Label

From the Trofinetide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Sensitive CYP3A and/or P-gp substrates
    What happensTrofinetide, a weak inhibitor of CYP3A and an inhibitor of P-gp, increased the plasma concentrations of CYP3A and/or P-gp substrates, which may increase the risk of adverse reactions associated with these substrates.
    What to doClosely monitor patients when given with sensitive CYP3A and/or P-gp substrates where minimal increases in plasma concentration may lead to serious adverse reactions.
Read the label’s full interactions text

7 DRUG INTERACTIONS Orally administered CYP3A and/or P-gp sensitive substrates for which a small change in substrate plasma concentration may lead to serious adverse reactions: closely monitor for adverse reactions with concomitant use. 7.1 Effect of DAYBUE and DAYBUE STIX on Other Drugs CYP3A and/or P-gp Substrates Closely monitor patients when DAYBUE or DAYBUE STIX is administered concomitantly with sensitive CYP3A and/or P-gp substrates where minimal increases in the plasma concentration of these substrates may lead to serious adverse reactions. Trofinetide, a weak inhibitor of CYP3A and an inhibitor of P-gp, increased the plasma concentrations of CYP3A and/or P-gp substrates, which may increase the risk of adverse reactions associated with these substrates.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • There are no listed contraindications.
  • Severe kidney impairment: not recommended.
  • Moderate kidney impairment: a reduced dose is recommended.
  • Pregnancy: not enough data in pregnant women.
  • Breastfeeding: effects on milk or infant are unknown.
  • Under 2 years old: safety and effectiveness not established.
  • Age 65 and older: not studied, and kidney function may be monitored.

Half-Life and How Your Body Processes It

Trofinetide is well absorbed by mouth and peaks in the blood about 2 to 3 hours after a dose. A high-fat meal did not change total exposure. Its half-life is about 1.5 hours.

It is not significantly broken down by liver enzymes. About 80% leaves the body unchanged in urine. Moderate kidney impairment raises exposure by roughly 80%, which is why the dose is lowered.

Storage

Store DAYBUE in an upright position refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Store DAYBUE STIX packets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) .

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Trofinetide

From the licensed clinical database we use, rolled up per supplement, most serious first.

30 supplements and herbal products have documented interactions with Trofinetide in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 19Moderate
  • 10Minor

See the other 22

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Trofinetide: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Trofinetide — the kind of thing our pharmacy team would talk through with you at the counter.

What is trofinetide for?

It treats Rett syndrome in adults and children 2 years and older. It is sold as Daybue and Daybue Stix. Doctors do not yet know exactly how it works in this condition.

How do I give it?

It is given twice a day, morning and evening, with or without food. It can be taken by mouth or through a G tube. Use a calibrated syringe or dosing cup from the pharmacy, not a kitchen spoon. If you use Daybue Stix, dissolve the whole packet in water or a water-based drink and give it right away.

What if a dose is missed or vomited?

If you miss a dose, just give the next one on time. Do not double up. If vomiting happens after a dose, do not give another. Wait for the next scheduled dose, and call your provider if vomiting is severe or keeps happening.

Will diarrhea be a problem?

It very likely will be, since most people in studies had it. It is usually mild or moderate. Stop laxatives before starting, keep up fluids, and let your provider know early. Call if it is severe or you worry about dehydration.

Are there other things I should watch for?

Yes. Keep an eye on weight, since weight loss can happen. Vomiting can lead to aspiration, where material gets into the lungs, so report any breathing trouble or repeated vomiting right away.

Does it interact with other medicines?

It can raise levels of some drugs that use the CYP3A or P-gp pathways, such as loperamide. Tell me or your prescriber about everything you take, so we can monitor for side effects.

Is trofinetide available over the counter?

No. Trofinetide is a prescription medicine: every trofinetide product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was trofinetide first available?

The earliest FDA record we hold for trofinetide is from 2022: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when trofinetide was first used.

What is the brand name of trofinetide?

Trofinetide is the generic name. Its brand names are Daybue and Daybue Stix.

What is the generic name of Daybue?

The generic name of Daybue is trofinetide. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What strengths does trofinetide come in?

Trofinetide is listed in the FDA's National Drug Code Directory in these forms and strengths. Oral solution (by mouth): 200 mg/mL, 5000 mg, 6000 mg and 8000 mg. A listing does not mean every pharmacy stocks every strength.

How much does trofinetide cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $23.73 per mL of the 200 mg/mL oral solution of brand-name Daybue over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a trofinetide shortage?

No. Trofinetide is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the trofinetide prescribing information (package insert)?

The full FDA-approved prescribing information for trofinetide, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Acadia Pharmaceuticals Inc.'s, revised Sep 4, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Trofinetide

Skip the scrolling. Ask in your own words and get an answer from Trofinetide’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Trofinetide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Trofinetide on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Trofinetide Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Trofinetide Forms and Strengths (How It Comes)

Trofinetide comes in 1 dose form, the oral solution. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Trofinetide inactive ingredients by manufacturer.

Oral solution

By mouth
Brands Daybue (2023) Daybue Stix (2025)
How this form is used
What it may be used for
  • Daybue and Daybue Stix are both used to treat Rett syndrome in adults and children 2 years and older.
Important instructions
  • Daybue is measured with a calibrated oral syringe or dosing cup from the pharmacy, not a household spoon. Discard unused solution 14 days after first opening the bottle.
  • Daybue Stix powder is dissolved in cold or room-temperature water or a water-based drink, then given right away. Do not use partial packets or save a prepared dose.
  • Daybue and Daybue Stix can be given by mouth or through a G tube, with or without food.
  • For moderate kidney impairment needing a dose under a full packet, Daybue oral solution is recommended instead of Daybue Stix.
Available strengths 4 strengths
4 FDA-listed product records ⓘ

Trofinetide on the U.S. Market: Products, Makers and Brands

How Trofinetide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 4 Trofinetide product records with the FDA, mostly as oral solution; the earliest marketing or approval year on record is 2022. Brand names in the directory today include Daybue and Daybue Stix; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
4
FDA-listed product records ⓘ
2022
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Trofinetide Is Used (Medicaid Data)

How many Trofinetide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

4,625
Medicaid prescriptions filled (Q1–Q4 2025)
$219.7M paid by Medicaid, before rebates

How commonly is Trofinetide prescribed? Of the 1,682 medications we measure, Trofinetide ranks #1,086 by Medicaid prescriptions — more than 35% of them.

Where Trofinetide ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Trofinetide product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

trofinetide 200 MG/ML Oral Solution

4,625 Medicaid prescriptions (Q1–Q4 2025) 100% of Trofinetide prescriptions shown $219.7M paid by Medicaid, before rebates ≈ $47,512 per prescription, before rebates

1 of 1 listed NDCs had Medicaid claims. RxNorm 2632857

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 1 listed Trofinetide NDCs had Medicaid claims.

Compare Trofinetide Products

A representative set of FDA-listed product records for Trofinetide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Oral solution
200 mg/mL Oral Acadia Pharmaceuticals Inc. NDA View NDC →
5000 mg Oral Acadia Pharmaceuticals Inc. NDA View NDC →
6000 mg Oral Acadia Pharmaceuticals Inc. NDA View NDC →
8000 mg Oral Acadia Pharmaceuticals Inc. NDA View NDC →

Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Trofinetide NDCs →

Trofinetide Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Trofinetide recalls since July 2021.

✅No Trofinetide recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Trofinetide in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
4
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Trofinetide RxCUI 2632852
  1. Dose form (SCDF) Oral Solution RxCUI 2632856
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Powder for Oral Solution RxCUI 2729446
    In current FDA listings
    Its 3 strengths (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Medicaid Pays for Trofinetide

CMS’s weekly pharmacy survey (NADAC) has no price for Trofinetide, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

FormStrengthVersion What Medicaid paid
Oral solution · Oral 200 mg/mL Daybue (brand) $23.73 per mL NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Trofinetide Brand Names

Trofinetide has 2 brand names on record: Daybue and Daybue Stix. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Daybue 2023 Daybue Stix 2025

Who Makes Trofinetide: Manufacturers and Labelers

One company lists Trofinetide products with the FDA. By number of product records, the largest are Acadia Pharmaceuticals Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Acadia Pharmaceuticals Inc. 4

Sources for This Trofinetide Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Sep 4, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Trofinetide.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
4
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Acadia Pharmaceuticals Inc.
Linked label effective
Sep 4, 2026
Composite sections available
21
Linked SPL Set ID
67e6f2d9-21f6-466f-9def-826c6a4b8257
Linked SPL Document ID
acf4551a-4f21-46d6-8575-0c553c2c6d39
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Acadia Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →